CMOs
The Translation of Next Generation Therapeutics
March 22 by Tony HitchcockWhen we look at the current trends with what we can refer to as “next generation therapeutics”, whether it be ADCs or cell and gene therapy products, one trend is very clear, products are becoming inc...
Serialisation Implementation Timeline
August 25 by Pharmaceuticals & Biotechnology EditorFollowing the release of the EU Falsified Medicines Directive, the pharma market is in the process of becoming fully serialised ahead of 2018’s deadline. Market players currently st...
Serialisation: Top Tech Integration Considerations
August 02 by Pharmaceuticals & Biotechnology EditorRoger Bate from the American Enterprise Institute estimates that global economy is hit by $10 billion in losses due to counterfeit and substandard medicines alone. Life loss, he estimates, equat...
Serialisation Deadlines- Printable WorldMap
July 28 by Pharmaceuticals & Biotechnology EditorAs the pharmaceutical industry prepares for various approaching serialisation deadlines all over the globe, Pharma IQ has created a printable map to assist with your worldwide compliance effor...
30 Pharmaceutical Contract Manufacturing Innovators to Watch in 2013
April 30 by Pharma IQThe list of winners from Life Science Leader's 2012 CMO Leadership Awards, based on research by Nice Insight, provides a good idea of which pharmaceutical contract manufacturers are set to make...
Global Insights on Pharmaceutical Contract Manufacturing
August 10 by Pharmaceuticals & Biotechnology EditorAgainst of backdrop of unsuccessful new drug discovery, patent expiry and a particularly tough global economic economy, the pharmaceutical industry model has had to change and over the last 10 years...
Selection of European CMOs for Therapeutic Proteins
April 11 by Pharmaceuticals & Biotechnology EditorNowadays, sponsors planning to perform a clinical trial with a therapeutic protein are spoilt by choices as quite a good number of Contract Manufacturing Organizations (CMOs) are available. The cont...
Pharma IQ Talking Heads - Global Pharmaceutical Contract Manufacturing Roundtable 2012
February 16 by Pharmaceuticals & Biotechnology EditorContract Manufacturing in Pharmaceuticals continues to increase… Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny....
Increasing Use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
February 07 by Pharma IQ NewsStrong Growth is expected in the Overall Upstream Process market Upstream process is vital in the manufacturing of biopharmaceuticals to have control over growth conditions and nutrients which eventu...
Using Industry Spending Data to Develop Strategic Marketing
January 17 by Kate HammekeFor CROs and CMOs to get the highest return on investment of marketing dollars, it is essential to develop marketing strategies that maximize opportunities to connect with potential partners. Knowin...
How Pharmaceutical Companies will Pick their Contract Manufacturing Organizations in 2012
December 02 by Pharmaceuticals & Biotechnology EditorTurn opportunity into reality! Now more than ever, it is more important to differentiate your company and the value it provides in the most cost effective manner! [inlinead]...
Choosing the Right Outsourcing Partner: 7 Reasons Why Not to Work with a Contract Manufacturing Organisation
December 01 by Pharmaceuticals & Biotechnology EditorChoosing a new contract manufacturing organisation (CMO) is not a decision to be entered into lightly. From identifying the outsourcing need to technology transfer, this complex pr...